Stone House Investment Management’s Editas Medicine EDIT Stock Holding History

Stone House Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.24K	Hold	1,000	–	–	﹤0.01%	644
2026 Q1	$2.47K	Hold	1,000	–	–	﹤0.01%	564
2025 Q4	$2.05K	Hold	1,000	–	–	﹤0.01%	553
2025 Q3	$3.47K	Hold	1,000	–	–	﹤0.01%	415
2025 Q2	$2.2K	Hold	1,000	–	–	﹤0.01%	405
2025 Q1	$1.16K	Buy	+1,000	New	+$1.47K	﹤0.01%	404
2024 Q4	–	Sell	-1,062	Closed	-$3.62K	–	148
2024 Q3	$3.62K	Hold	1,062	–	–	﹤0.01%	300
2024 Q2	$4.96K	Hold	1,062	–	–	﹤0.01%	274
2024 Q1	$7.88K	Hold	1,062	–	–	﹤0.01%	250
2023 Q4	$10.8K	Hold	1,062	–	–	﹤0.01%	158
2023 Q3	$8.28K	Hold	1,062	–	–	﹤0.01%	174
2023 Q2	$8.74K	Hold	1,062	–	–	﹤0.01%	171
2023 Q1	$7.7K	Buy	+1,062	New	+$9.44K	﹤0.01%	180
2019 Q2	–	Sell	-1,000	Closed	-$24K	–	76
2019 Q1	$24K	Buy	+1,000	New	+$22.6K	0.01%	127

Other funds holding EDIT

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Stone House Investment Management's EDIT Position: Q2 2026 in Review

Stone House Investment Management held its Editas Medicine (EDIT) position steady in Q2 2026 at 1,000 shares worth $3.24K. The position accounts for ﹤0.01% of the portfolio, ranked #644.

Stone House Investment Management first reported a position in EDIT in Q1 2019 and has held it in 14 quarters since. The position peaked at $24K in Q1 2019. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Stone House Investment Management held 1,000 shares of Editas Medicine worth $3.24K as of Q2 2026.
Stone House Investment Management left its Editas Medicine share count unchanged in Q2 2026.
Editas Medicine made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #644 holding.
Stone House Investment Management first reported a position in Editas Medicine in Q1 2019 and has held it in 14 quarters since.
Stone House Investment Management's Editas Medicine position peaked at $24K in Q1 2019.
215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.